See if virtual reality can help MI patients in ICU feel less anxious and have steadier vital signs
Official title: The Effect of Virtual Reality on Vital Signs and Anxiety in Myocardial Infarction Patients Admitted to Cardiology Intensive Care Unit: A Randomized Controlled Study.
Run by Yuzuncu Yil University · NCT07696390 · Data updated 2026-11-12
A VR glasses intervention is tested in conscious MI patients in the ICU to see if it changes their vital signs and anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Yuzuncu Yil University Academic / other |
| Locations | 1 site (Van) |
| Status | Recruiting |
| Started | July 10, 2026 |
| Main results expected | September 18, 2026 |
| Study ends | September 18, 2026 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT07696390 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 with STEMI who are conscious, oriented, cooperative, and have undergone stent placement in the cardiology ICU.
✕Probably not a fit
Patients with psychiatric, sensory, or communication impairments, or those outside the ICU setting, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized design tests whether applying virtual reality glasses to conscious MI patients in the cardiology ICU affects physiological measures (blood pressure, heart rate, oxygen saturation, and respiratory rate) and anxiety. The study targets adults up to 70 years old who have STEMI and have undergone stent placement, and who are oriented and cooperative. Outcome data from this intervention could inform how technology like VR might support cardiovascular care in critical settings.
Why it matters
Potential benefit: If successful, VR could provide a nonpharmacologic way to reduce anxiety and stabilize vital signs in MI patients.
How similar studies have gone: Previous research on VR in MI or cardiology ICU patients is limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patient is in intensive care. 2. The patient has been diagnosed with myocardial infarction. 3. The patient is between 18 and 70 years old. 4. The patient is conscious. 5. The patient is oriented and cooperative. 6. The patient volunteers to participate in the study. 7. The patient is open to communication. 8. The patient agrees to participate in the study. 9. The patient has no mental, visual, auditory, or speech impairment. 10. The patient has undergone stent placement. 11. The patient has STEMI. Exclusion Criteria: 1. The patient has a psychiatric disorder. 2. The patient has any communication impairment.
Where it's running
-
SBU Van Training and Research Hospital
Van, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yavuz Uren, Asst.Prof.
- Email: yavuzuren@yyu.edu.tr
- Phone: +905065961050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Digital cardiac rehab to help heart attack patients improve function
A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Innate Immune Cells and Early Fibrotic Repair After a Heart Attack
This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.